Please select the option that best describes you:

Topics: Diabetes • Endocrinology

Is the combination of SGLT2i and GLP 1 R agonist therapy contra-indicated in patients who develop an episode of euglycemic DKA?

Classic diabetic ketoacidosis and the euglycemic variant: Something old, something new | Cleveland Clinic Journal of Medicine